Liaoning Chengda
Chinese listed conglomerate with activities spanning international trade, fertilizers, pharmaceuticals, vaccines, property leasing, and warehousing.
Last updated November 4, 2026
AI crawler reads
6requests
1companies- Anthropic6
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Liaoning Chengda Company Limited is a diversified Chinese conglomerate headquartered in Dalian, Liaoning Province. Its business portfolio combines trading and industrial activities rather than being centered on a single consumer-facing product category. The company is associated with import and export operations, trading, chemical fertilizers, pharmaceuticals, biological vaccine activities, property leasing, and warehousing. The company was established in 1993 under the name Liaoning Knitwear and Home-Textiles Import & Export Company. This origin placed it within the foreign-trade and import-export environment of Liaoning, a northeastern Chinese province with an important industrial and port-based commercial economy. Over time, the enterprise broadened beyond its original textile and home-textiles trading base, developing a more diversified operating structure that included industrial materials, healthcare-related businesses, real estate-related income, and logistics assets. Liaoning Chengda became a publicly traded company when its A shares were listed on the Shanghai Stock Exchange in 1996. The listing provided a public-market platform for the company as it expanded and reorganized its business interests. Its exchange identity is SSE: 600739. The company is described as a state-owned conglomerate enterprise, although the available reference material does not identify a specific controlling parent or provide a current ownership breakdown. A significant part of Liaoning Chengda’s modern profile comes from its connection with biopharmaceutical and vaccine activities. Its subsidiary Chengda Bio is associated with biological vaccine products, giving the broader group exposure to the pharmaceutical and life-sciences sector. The available reference does not provide a sufficiently detailed product catalogue, market-share record, or current revenue contribution for these activities, so the vaccine business is best understood as an important component of the group rather than the group’s sole identity. The company’s other disclosed activities include chemical-fertilizer trading or related commerce, general import and export, property leasing, and warehousing. These businesses give Liaoning Chengda a mixed portfolio that combines commercial services, physical goods, healthcare products, and asset-based operations. Its positioning is therefore that of a diversified, state-linked Chinese corporate group with a notable biopharmaceutical presence, rather than a narrowly focused brand marketed directly to consumers. Publicly available reference material supplied for this entry does not establish a current chief executive, detailed corporate milestones after the 1996 listing, major advertising campaigns, litigation or scandal history, or recent financial figures. Those fields are consequently left unreported rather than inferred.
History
Liaoning Chengda traces its origins to 1993, when it was established as Liaoning Knitwear and Home-Textiles Import & Export Company. The original business identity indicates a foreign-trade foundation, with the company initially focused on the import and export of knitwear and home-textile goods. This starting point was consistent with the role of northeastern Chinese trading enterprises that connected regional production with domestic and overseas markets. The company subsequently developed beyond its initial textile-trading scope. Its business portfolio came to include broader import and export operations, general trading, chemical fertilizers, pharmaceuticals, biological vaccines, property leasing, and warehousing. This expansion transformed the enterprise from a relatively specialized foreign-trade company into a diversified corporate group with commercial, industrial, healthcare, real-estate, and logistics interests. Liaoning Chengda’s shares were listed on the Shanghai Stock Exchange in 1996. The Shanghai listing, under stock code 600739, marked an important institutional transition by making the company a publicly traded enterprise and giving it access to public capital markets. The company is identified in reference material as a state-owned conglomerate enterprise headquartered in Dalian, Liaoning. In its later development, healthcare and biopharmaceutical activities became an important part of the group’s profile. Through Chengda Bio, Liaoning Chengda has a connection to biological vaccine production and related pharmaceutical operations. The available sources do not provide enough detail to reconstruct the subsidiary’s full development history, individual vaccine launches, or the precise relationship between its results and those of the listed parent. It is nevertheless clear that vaccine and biological-product activities distinguish Liaoning Chengda from a conventional trading company. Alongside biopharmaceutical operations, the group has retained a diversified commercial structure. Trading and import-export businesses remain part of its identity, while chemical-fertilizer activities connect it with agricultural-input commerce. Property leasing and warehousing add recurring asset and logistics-related operations to the portfolio. The combination reflects a conglomerate model in which the listed company manages or holds interests across several sectors rather than concentrating exclusively on one product market. The supplied reference material does not document a complete sequence of reorganizations, acquisitions, leadership changes, financial results, or post-listing strategic decisions. It also does not establish a specific current controlling shareholder, chief executive, or official corporate website. Accordingly, the documented history is limited to the company’s 1993 establishment, its original foreign-trade identity, its 1996 Shanghai Stock Exchange listing, and its subsequent diversification into trading, fertilizers, pharmaceuticals, vaccines, property leasing, and warehousing.
- 1996
A shares listed on the Shanghai Stock Exchange
[1]Liaoning Chengda’s A shares were listed on the Shanghai Stock Exchange under stock code 600739, establishing its public-company identity.
- 1993
Established as a textile and home-textiles import-export company
[1]The enterprise was founded as Liaoning Knitwear and Home-Textiles Import & Export Company, beginning with an international-trade-oriented business focused on knitwear and home textiles.
Products and positioning
Diversified Chinese conglomerate combining international trade, industrial and agricultural-input commerce, pharmaceuticals and vaccines, property leasing, and warehousing.
Trading services · 1993
International trade and import-export services
International trade is part of Liaoning Chengda’s original and continuing business identity. The company began as a knitwear and home-textiles import-export enterprise and later operated across broader export, import, and trading activities. The available reference does not specify individual trade brands, principal destinations, or current product volumes.
Agricultural inputs
Chemical fertilizers
Chemical fertilizers are among the trading or industrial product areas associated with Liaoning Chengda. This activity connects the group with agricultural-input commerce, although the supplied sources do not identify specific fertilizer formulations, proprietary brands, production facilities, or distribution territories.
Pharmaceuticals
Pharmaceutical products
Liaoning Chengda has pharmaceutical activities within its diversified portfolio. The available reference material confirms the sector but does not provide a complete list of medicines, therapeutic areas, regulatory approvals, or sales markets.
Vaccines and biological products
Biological vaccine products
Biological vaccine products are associated with Chengda Bio, a subsidiary connected to Liaoning Chengda. This business gives the listed group a notable presence in biopharmaceuticals. The supplied sources do not establish a detailed product-by-product history or identify specific vaccine trade names.
Real estate services
Property leasing
Property leasing is one of the non-trading activities included in Liaoning Chengda’s business scope. It represents an asset-based source of activity alongside the group’s commercial and healthcare operations. No specific properties or geographic portfolio details are identified in the supplied reference.
Logistics and storage
Warehousing
Warehousing forms part of Liaoning Chengda’s logistics-related business activities. It complements the group’s trading and import-export operations by providing storage capabilities, although the available material does not specify facilities, capacity, or third-party logistics customers.
Controversies
2022
Liaoning Chengda ordered to rectify by Dalian CSRC bureau over related-party fund disclosure and internal control issues
The Dalian CSRC bureau took corrective measures against Liaoning Chengda, involving disclosure of related-party fund transactions, registration of insiders, presentation of transportation expenses and internal control issues, and required a rectification report to be submitted within 30 days. Progress: regulatory measure. Subject involved: Liaoning Chengda Co., Ltd. Scope: listed company information disclosure.
Recent events
Reported
Liaoning Cheng Da signs contract to transfer Chengda Fangyuan equity[3]
The Dalian exchange confirmed that Liaoning Cheng Da had signed a contract with Guoda Pharmacy to transfer its 100% equity stake in Chengda Fangyuan for RMB 1.86 billion. The ownership-change procedures were still in progress.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/liaoning-chengda · Editorial policy · How profiles are compiled